TP53 and breast cancer: Together, WES and sWGS analyses suggest that the subtype-specific somatic SNVs, indels, CNA and CCF patterns in our cohort are similar to that previously described in other Asian or European populations, with the notable exception that TP53 mutations are more common in ER+ Asian breast cancers.